Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 Dec 1;182(6):1717–1726. doi: 10.1084/jem.182.6.1717

A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor

PMCID: PMC2192234  PMID: 7500016

Abstract

Immunoglobulin G-binding factors (IgG-BF), which are produced by cells of the immune system, inhibit antibody production. In this paper, we show that transforming growth factor-beta (TGF-beta) suppresses secondary in vitro anti-sheep red blood cell responses of mouse splenocytes and lipopolysaccharide- or anti-IgM-stimulated mouse B cell responses in a way similar to, and with the same kinetics as, rodent IgG-BF. Moreover, the immunosuppressive activity of IgG-BF was totally neutralized by polyclonal and monoclonal anti-TGF-beta antibodies and it eluted with TGF-beta by gel exclusion chromatography, suggesting that a TGF-beta-like immunosuppressive factor is present in IgG-BF. We also show that TGF-beta behaves as an IgG-BF since it binds to insolubilized IgG, but not to insolubilized F(ab')2 or bovine serum albumin. Altogether, the data support the concept of a biological role for TGF-beta in the IgG-mediated negative feedback of antibody responses.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. J., Schneider S. L., Thompson D. A., Cheng H. L., Tomasi T. B. A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus. J Exp Med. 1990 Nov 1;172(5):1391–1401. doi: 10.1084/jem.172.5.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amigorena S., Bonnerot C., Drake J. R., Choquet D., Hunziker W., Guillet J. G., Webster P., Sautes C., Mellman I., Fridman W. H. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science. 1992 Jun 26;256(5065):1808–1812. doi: 10.1126/science.1535455. [DOI] [PubMed] [Google Scholar]
  3. Bich-Thuy L. T., Revillard J. P. Selective suppression of human B lymphocyte differentiation into IgG-producing cells by soluble Fc gamma receptors. J Immunol. 1982 Jul;129(1):150–152. [PubMed] [Google Scholar]
  4. Blank U., Fridman W. H., Daëron M., Galinha A., Moncuit J., Néauport-Sautès C. Size and charge heterogeneity of murine IgG-binding factors (IgG-BF). J Immunol. 1986 Apr 15;136(8):2975–2982. [PubMed] [Google Scholar]
  5. Bouchard C., Fridman W. H., Sautès C. Mechanism of inhibition of lipopolysaccharide-stimulated mouse B-cell responses by transforming growth factor-beta 1. Immunol Lett. 1994 May;40(2):105–110. doi: 10.1016/0165-2478(94)90180-5. [DOI] [PubMed] [Google Scholar]
  6. Bourdrel L., Lin C. H., Lauren S. L., Elmore R. H., Sugarman B. J., Hu S., Westcott K. R. Recombinant human transforming growth factor-beta 1: expression by Chinese hamster ovary cells, isolation, and characterization. Protein Expr Purif. 1993 Apr;4(2):130–140. doi: 10.1006/prep.1993.1019. [DOI] [PubMed] [Google Scholar]
  7. Brown P. D., Wakefield L. M., Levinson A. D., Sporn M. B. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors. 1990;3(1):35–43. doi: 10.3109/08977199009037500. [DOI] [PubMed] [Google Scholar]
  8. Coffman R. L., Lebman D. A., Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol. 1993;54:229–270. doi: 10.1016/s0065-2776(08)60536-2. [DOI] [PubMed] [Google Scholar]
  9. Daley M. J., Nakamura M., Gefter M. L. Functional and biochemical characterization of a secreted I-J(+) suppressor factor that binds to immunoglobulin. J Exp Med. 1986 Jun 1;163(6):1415–1432. doi: 10.1084/jem.163.6.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Daëron M., Sautès C., Bonnerot C., Blank U., Varin N., Even J., Hogarth P. M., Fridman W. H. Murine type II Fc gamma receptors and IgG-binding factors. Chem Immunol. 1989;47:21–78. doi: 10.1159/000318912. [DOI] [PubMed] [Google Scholar]
  11. Fava R. A., McClure D. B. Fibronectin-associated transforming growth factor. J Cell Physiol. 1987 May;131(2):184–189. doi: 10.1002/jcp.1041310207. [DOI] [PubMed] [Google Scholar]
  12. Flaumenhaft R., Kojima S., Abe M., Rifkin D. B. Activation of latent transforming growth factor beta. Adv Pharmacol. 1993;24:51–76. doi: 10.1016/s1054-3589(08)60933-3. [DOI] [PubMed] [Google Scholar]
  13. Fridman W. H., Bonnerot C., Daeron M., Amigorena S., Teillaud J. L., Sautes C. Structural bases of Fc gamma receptor functions. Immunol Rev. 1992 Feb;125:49–76. doi: 10.1111/j.1600-065x.1992.tb00625.x. [DOI] [PubMed] [Google Scholar]
  14. Fridman W. H., Gelabert M. J., Daëron M., Moncuit J., Löwy I., Thèze J., Néauport-Sautès C. IgG-binding factors. Methods Enzymol. 1985;116:403–416. doi: 10.1016/s0076-6879(85)16032-5. [DOI] [PubMed] [Google Scholar]
  15. Fridman W. H., Golstein P. Immunoglobulin-binding factor present on and produced by thymus-processed lymphocytes (T cells). Cell Immunol. 1974 Mar 30;11(1-3):442–455. doi: 10.1016/0008-8749(74)90042-2. [DOI] [PubMed] [Google Scholar]
  16. Fridman W. H., Rabourdin-Combe C., Neauport-Sautes C., Gisler R. H. Characterization and function of T cell Fc gamma receptor. Immunol Rev. 1981;56:51–88. doi: 10.1111/j.1600-065x.1981.tb01047.x. [DOI] [PubMed] [Google Scholar]
  17. Fridman W. H., Teillaud J. L., Bouchard C., Teillaud C., Astier A., Tartour E., Galon J., Mathiot C., Sautès C. Soluble Fc gamma receptors. J Leukoc Biol. 1993 Nov;54(5):504–512. [PubMed] [Google Scholar]
  18. Gisler R. H., Fridman W. H. Inhibition of the in vitro 19S and 7S antibody response by immunoglobulin-binding factor (IBF) from alloantigen-activated T cells. Cell Immunol. 1976 Apr;23(1):99–107. doi: 10.1016/0008-8749(76)90174-x. [DOI] [PubMed] [Google Scholar]
  19. Gisler R. H., Fridman W. H. Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. J Exp Med. 1975 Aug 1;142(2):507–517. doi: 10.1084/jem.142.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lawrence D. A., Pircher R., Jullien P. Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun. 1985 Dec 31;133(3):1026–1034. doi: 10.1016/0006-291x(85)91239-2. [DOI] [PubMed] [Google Scholar]
  21. Lucas C., Bald L. N., Fendly B. M., Mora-Worms M., Figari I. S., Patzer E. J., Palladino M. A. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol. 1990 Sep 1;145(5):1415–1422. [PubMed] [Google Scholar]
  22. Löwy I., Brezin C., Neauport-Sautes C., Theze J., Fridman W. H. Isotype regulation of antibody production: T-cell hybrids can be selectively induced to produce IgG1 and IgG2 subclass-specific suppressive immunoglobulin-binding factors. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2323–2327. doi: 10.1073/pnas.80.8.2323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6:597–641. doi: 10.1146/annurev.cb.06.110190.003121. [DOI] [PubMed] [Google Scholar]
  24. McCartney-Francis N. L., Wahl S. M. Transforming growth factor beta: a matter of life and death. J Leukoc Biol. 1994 Mar;55(3):401–409. doi: 10.1002/jlb.55.3.401. [DOI] [PubMed] [Google Scholar]
  25. McIntyre T. M., Klinman D. R., Rothman P., Lugo M., Dasch J. R., Mond J. J., Snapper C. M. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med. 1993 Apr 1;177(4):1031–1037. doi: 10.1084/jem.177.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. O'Connor-McCourt M. D., Wakefield L. M. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem. 1987 Oct 15;262(29):14090–14099. [PubMed] [Google Scholar]
  27. Paul W. E., Seder R. A. Lymphocyte responses and cytokines. Cell. 1994 Jan 28;76(2):241–251. doi: 10.1016/0092-8674(94)90332-8. [DOI] [PubMed] [Google Scholar]
  28. Phillips N. E., Parker D. C. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol. 1984 Feb;132(2):627–632. [PubMed] [Google Scholar]
  29. Pircher R., Jullien P., Lawrence D. A. Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem Biophys Res Commun. 1986 Apr 14;136(1):30–37. doi: 10.1016/0006-291x(86)90872-7. [DOI] [PubMed] [Google Scholar]
  30. Ravetch J. V., Kinet J. P. Fc receptors. Annu Rev Immunol. 1991;9:457–492. doi: 10.1146/annurev.iy.09.040191.002325. [DOI] [PubMed] [Google Scholar]
  31. Sautès C., Varin N., Teillaud C., Daëron M., Even J., Hogarth P. M., Fridman W. H. Soluble Fc gamma receptors II (Fc gamma RII) are generated by cleavage of membrane Fc gamma RII. Eur J Immunol. 1991 Jan;21(1):231–234. doi: 10.1002/eji.1830210135. [DOI] [PubMed] [Google Scholar]
  32. Segarini P. R. TGF-beta receptors: a complicated system of multiple binding proteins. Biochim Biophys Acta. 1993 Dec 23;1155(3):269–275. doi: 10.1016/0304-419x(93)90009-2. [DOI] [PubMed] [Google Scholar]
  33. Stach R. M., Rowley D. A. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med. 1993 Sep 1;178(3):841–852. doi: 10.1084/jem.178.3.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tartour E., de la Salle H., de la Salle C., Teillaud C., Camoin L., Galinha A., Latour S., Hanau D., Fridman W. H., Sautès C. Identification, in mouse macrophages and in serum, of a soluble receptor for the Fc portion of IgG (Fc gamma R) encoded by an alternatively spliced transcript of the Fc gamma RII gene. Int Immunol. 1993 Aug;5(8):859–868. doi: 10.1093/intimm/5.8.859. [DOI] [PubMed] [Google Scholar]
  35. Teillaud J. L., Bouchard C., Astier A., Teillaud C., Tartour E., Michon J., Galinha A., Moncuit J., Mazières N., Spagnoli R. Natural and recombinant soluble low-affinity Fc gamma R: detection, purification, and functional activities. Immunomethods. 1994 Feb;4(1):48–64. doi: 10.1006/immu.1994.1007. [DOI] [PubMed] [Google Scholar]
  36. Unkeless J. C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979 Sep 19;150(3):580–596. doi: 10.1084/jem.150.3.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Varin N., Sautès C., Galinha A., Even J., Hogarth P. M., Fridman W. H. Recombinant soluble receptors for the Fc gamma portion inhibit antibody production in vitro. Eur J Immunol. 1989 Dec;19(12):2263–2268. doi: 10.1002/eji.1830191213. [DOI] [PubMed] [Google Scholar]
  38. Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990 Jul 19;346(6281):281–284. doi: 10.1038/346281a0. [DOI] [PubMed] [Google Scholar]
  39. Yamamoto H., Hirayama M., Genyea C., Kaplan J. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J Immunol. 1994 Apr 15;152(8):3842–3847. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES